HIV‐1 Integrase 2011
DOI: 10.1002/9781118015377.ch23
|View full text |Cite
|
Sign up to set email alerts
|

Dicaffeoyltartaric Acid and Dicaffeoylquinic Acid HIV Integrase Inhibitors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2012
2012
2015
2015

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 35 publications
0
1
0
Order By: Relevance
“…The first drug using integrase inhibitor (Raltegravir) was approved by the US Food and Drug Administration (FDA) in 2007 while still others are being actively tested in clinical trials [10]. The focus on integrase inhibitors, especially L-chicoric acid for developing successful anti-HIV drug therapy, has been a promising area of study [3,[10][11][12].…”
Section: Introductionmentioning
confidence: 99%
“…The first drug using integrase inhibitor (Raltegravir) was approved by the US Food and Drug Administration (FDA) in 2007 while still others are being actively tested in clinical trials [10]. The focus on integrase inhibitors, especially L-chicoric acid for developing successful anti-HIV drug therapy, has been a promising area of study [3,[10][11][12].…”
Section: Introductionmentioning
confidence: 99%